.png)
Plasma-Derived Drugs Market by Product Type and End User - Global Industry Analysis & Forecast to 2027
Published On : August 2019 Pages : 152 Category: Biotechnology Report Code : HC085036
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Plasma-Derived Drugs Market By Product Type (Immunoglobulins, Albumins, Clotting factors and Other) and End User (Hospital, Ambulatory Surgical Centers, Specialty Clinic and Home care setting) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
Plasma as a constituent is the rest of the piece of the blood after the extraction of red platelets, white platelets. It is capable in shipping supplements, catalysts, hormones, and proteins to different piece of the body. Plasma holds significant properties, significant characters which are in charge of the assembling of life sparing proteins of clinical centrality. There are significant variables which can be extricated from the plasma, incorporate egg whites, FVII, IVIG that are presently better balanced and known as plasma-determined medications for extreme wellbeing conditions.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Power Tools market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The North America locale is assessed to have a noteworthy offer in the plasma-inferred medications showcase, attributable to its quality foundation supporting the need of plasma-determined medications.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Grifols
- Octa Pharma
- CSL Limited
- S.A.
- Antaris Pharma
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Plasma-Derived Drugs Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)
o Immunoglobulins
o Albumins
o Clotting factors
o Other
· Plasma-Derived Drugs Market, By End User, Estimates and Forecast, 2017-2027 ($Million)
o Hospital
o Ambulatory Surgical Centers
o Specialty Clinic
o Home care setting
· Plasma-Derived Drugs Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Grifols
o Octa Pharma
o CSL Limited
o S.A.
o Antaris Pharma
· Plasma-Derived Drugs Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Plasma-Derived Drugs Market, By Country
o U.S. Plasma-Derived Drugs Market
o Canada Plasma-Derived Drugs Market
o Mexico Plasma-Derived Drugs Market
o Europe
§ Europe Plasma-Derived Drugs Market, By Country
o Germany Plasma-Derived Drugs Market
o UK Plasma-Derived Drugs Market
o France Plasma-Derived Drugs Market
o Russia Plasma-Derived Drugs Market
o Italy Plasma-Derived Drugs Market
o Rest of Europe Plasma-Derived Drugs Market
o Asia-Pacific
§ Asia-Pacific Plasma-Derived Drugs Market, By Country
o China Plasma-Derived Drugs Market
o Japan Plasma-Derived Drugs Market
o South Korea Plasma-Derived Drugs Market
o India Plasma-Derived Drugs Market
o Southeast Asia Plasma-Derived Drugs Market
o Rest of Asia-Pacific Plasma-Derived Drugs Market
o South America
§ South America Plasma-Derived Drugs Market
o Brazil Plasma-Derived Drugs Market
o Argentina Plasma-Derived Drugs Market
o Columbia Plasma-Derived Drugs Market
o Rest of South America Plasma-Derived Drugs Market
o Middle East and Africa
§ Middle East and Africa Plasma-Derived Drugs Market
o Saudi Arabia Plasma-Derived Drugs Market
o UAE Plasma-Derived Drugs Market
o Egypt Plasma-Derived Drugs Market
o Nigeria Plasma-Derived Drugs Market
o South Africa Plasma-Derived Drugs Market
o Rest of MEA Plasma-Derived Drugs Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Plasma-Derived Drugs Market, By Product Type
5.1. Introduction
5.2. Global Plasma-Derived Drugs Revenue and Market Share by Product Type (2017-2027)
5.2.1. Global Plasma-Derived Drugs Revenue and Revenue Share by Product Type (2017-2027)
5.3. Immunoglobulins
5.3.1. Global Immunoglobulins Revenue and Growth Rate (2017-2027)
5.4. Albumins
5.4.1. Global Albumins Revenue and Growth Rate (2017-2027)
5.5. Clotting factors
5.5.1. Global Clotting factors Revenue and Growth Rate (2017-2027)
5.6. Other
5.6.1. Global Other Revenue and Growth Rate (2017-2027)
6. Plasma-Derived Drugs Market, By End User
6.1. Introduction
6.2. Global Plasma-Derived Drugs Revenue and Market Share by End User (2017-2027)
6.2.1. Global Plasma-Derived Drugs Revenue and Revenue Share by End User (2017-2027)
6.3. Hospital
6.3.1. Global Hospital Revenue and Growth Rate (2017-2027)
6.4. Ambulatory Surgical Centers
6.4.1. Global Ambulatory Surgical Centers Revenue and Growth Rate (2017-2027)
6.5. Specialty Clinic
6.5.1. Global Specialty Clinic Revenue and Growth Rate (2017-2027)
6.6. Home care setting
6.6.1. Global Home care setting Revenue and Growth Rate (2017-2027)
7. Plasma-Derived Drugs Market, By Region
7.1. Introduction
7.2. Global Plasma-Derived Drugs Revenue and Market Share by Regions
7.2.1. Global Plasma-Derived Drugs Revenue by Regions (2017-2027)
7.3. North America Plasma-Derived Drugs by Countries
7.3.1. North America Plasma-Derived Drugs Revenue and Growth Rate (2017-2027)
7.3.2. North America Plasma-Derived Drugs Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Plasma-Derived Drugs by Countries
7.4.1. Europe Plasma-Derived Drugs Revenue and Growth Rate (2017-2027)
7.4.2. Europe Plasma-Derived Drugs Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Plasma-Derived Drugs by Countries
7.5.1. Asia-Pacific Plasma-Derived Drugs Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Plasma-Derived Drugs Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Plasma-Derived Drugs by Countries
7.6.1. South America Plasma-Derived Drugs Revenue and Growth Rate (2017-2027)
7.6.2. South America Plasma-Derived Drugs Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Plasma-Derived Drugs by Countries
7.7.1. Middle East and Africa Plasma-Derived Drugs Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Plasma-Derived Drugs Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Grifols
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Octa Pharma
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. CSL Limited
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. S.A.
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Antaris Pharma
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
9. Plasma-Derived Drugs Market Forecast (2017-2027)
9.1. Global Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Plasma-Derived Drugs Market Forecast by Regions (2017-2027)
9.2.1. North America Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.1.1. United States Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.1.2. Canada Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.1.3. Mexico Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.2. Europe Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.2.1. Germany Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.2.2. France Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.2.3. UK Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.2.4. Russia Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.2.5. Italy Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.3. Asia-Pacific Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.3.1. China Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.3.2. Japan Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.3.3. Korea Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.3.4. India Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.4. South America Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.4.1. Brazil Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.4.2. Argentina Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.4.3. Columbia Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.4.4. Rest of South America Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.5. Middle East and Africa Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.5.3. Egypt Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.5.4. Nigeria Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.5.5. South Africa Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.5.6. Turkey Plasma-Derived Drugs Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Plasma-Derived Drugs Market Forecast (2017-2027)
9.3. Plasma-Derived Drugs Market Forecast by Product Type (2017-2027)
9.3.1. Plasma-Derived Drugs Forecast by Product Type (2017-2027)
9.3.2. Plasma-Derived Drugs Market Share Forecast by Product Type (2017-2027)
9.4. Plasma-Derived Drugs Market Forecast by End User (2017-2027)
9.4.1. Plasma-Derived Drugs Forecast by End User (2017-2027)
9.4.2. Plasma-Derived Drugs Market Share Forecast by End User (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Plasma-Derived Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Plasma-Derived Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Plasma-Derived Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Plasma-Derived Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Plasma-Derived Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Plasma-Derived Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Plasma-Derived Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Plasma-Derived Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Plasma-Derived Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Plasma-Derived Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Plasma-Derived Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Plasma-Derived Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Plasma-Derived Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Plasma-Derived Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Plasma-Derived Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Plasma-Derived Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Plasma-Derived Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Plasma-Derived Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Plasma-Derived Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Plasma-Derived Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Plasma-Derived Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Plasma-Derived Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Plasma-Derived Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Plasma-Derived Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Plasma-Derived Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Plasma-Derived Drugs Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Plasma-Derived Drugs Revenue and Revenue Share by Product Type (2017-2018)
Figure Global Immunoglobulins Revenue and Growth Rate (2017-2018)
Figure Global Albumins Revenue and Growth Rate (2017-2018)
Figure Global Clotting factors Revenue and Growth Rate (2017-2018)
Figure Global Other Revenue and Growth Rate (2017-2018)
Table Global Plasma-Derived Drugs Revenue and Revenue Share by End User (2017-2018)
Figure Global Hospital Revenue and Growth Rate (2017-2018)
Figure Global Ambulatory Surgical Centers Revenue and Growth Rate (2017-2018)
Figure Global Specialty Clinic Revenue and Growth Rate (2017-2018)
Figure Global Home care setting Revenue and Growth Rate (2017-2018)
Table Global Plasma-Derived Drugs Revenue by Regions (2017-2018)
Figure North America Plasma-Derived Drugs Growth Rate (2017-2018)
Figure North America Plasma-Derived Drugs Revenue and Growth Rate (2017-2018)
Figure North America Plasma-Derived Drugs by Countries (2017-2018)
Figure North America Plasma-Derived Drugs Revenue (Million USD) by Countries (2017-2018)
Figure United States Plasma-Derived Drugs Growth Rate (2017-2018)
Figure United States Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Plasma-Derived Drugs Growth Rate (2017-2018)
Figure Canada Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Plasma-Derived Drugs Growth Rate (2017-2018)
Figure Mexico Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Plasma-Derived Drugs Growth Rate (2017-2018)
Figure Europe Plasma-Derived Drugs Revenue and Growth Rate (2017-2018)
Figure Europe Plasma-Derived Drugs by Countries (2017-2018)
Figure Europe Plasma-Derived Drugs Revenue (Million USD) by Countries (2017-2018)
Figure Germany Plasma-Derived Drugs Growth Rate (2017-2018)
Figure Germany Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Plasma-Derived Drugs Growth Rate (2017-2018)
Figure France Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Plasma-Derived Drugs Growth Rate (2017-2018)
Figure UK Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Plasma-Derived Drugs Growth Rate (2017-2018)
Figure Russia Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Plasma-Derived Drugs Growth Rate (2017-2018)
Figure Italy Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Plasma-Derived Drugs Growth Rate (2017-2018)
Figure Rest of Europe Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Plasma-Derived Drugs Growth Rate (2017-2018)
Figure Asia-Pacific Plasma-Derived Drugs Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Plasma-Derived Drugs by Countries (2017-2018)
Figure Asia-Pacific Plasma-Derived Drugs Revenue (Million USD) by Countries (2017-2018)
Figure China Plasma-Derived Drugs Growth Rate (2017-2018)
Figure China Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Plasma-Derived Drugs Growth Rate (2017-2018)
Figure Japan Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Plasma-Derived Drugs Growth Rate (2017-2018)
Figure Korea Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Plasma-Derived Drugs Growth Rate (2017-2018)
Figure India Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Plasma-Derived Drugs Growth Rate (2017-2018)
Figure Southeast Asia Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Plasma-Derived Drugs Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Plasma-Derived Drugs Growth Rate (2017-2018)
Figure South America Plasma-Derived Drugs Revenue and Growth Rate (2017-2018)
Figure South America Plasma-Derived Drugs by Countries (2017-2018)
Figure South America Plasma-Derived Drugs Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Plasma-Derived Drugs Growth Rate (2017-2018)
Figure Brazil Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Plasma-Derived Drugs Growth Rate (2017-2018)
Figure Argentina Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Plasma-Derived Drugs Growth Rate (2017-2018)
Figure Columbia Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Plasma-Derived Drugs Growth Rate (2017-2018)
Figure Rest of South America Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Plasma-Derived Drugs Growth Rate (2017-2018)
Figure Middle East and Africa Plasma-Derived Drugs Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Plasma-Derived Drugs by Countries (2017-2018)
Figure Middle East and Africa Plasma-Derived Drugs Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Plasma-Derived Drugs Growth Rate (2017-2018)
Figure Saudi Arabia Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Plasma-Derived Drugs Growth Rate (2017-2018)
Figure United Arab Emirates Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Plasma-Derived Drugs Growth Rate (2017-2018)
Figure Egypt Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Plasma-Derived Drugs Growth Rate (2017-2018)
Figure Nigeria Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Plasma-Derived Drugs Growth Rate (2017-2018)
Figure South Africa Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Plasma-Derived Drugs Growth Rate (2017-2018)
Figure Turkey Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Plasma-Derived Drugs Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2017-2018)
Table Grifols Plasma-Derived Drugs Financial Overview
Table Octa Pharma Plasma-Derived Drugs Financial Overview
Table CSL Limited Plasma-Derived Drugs Financial Overview
Table S.A. Plasma-Derived Drugs Financial Overview
Table Antaris Pharma Plasma-Derived Drugs Financial Overview
Figure Global Plasma-Derived Drugs Revenue (Millions USD) and Growth Rate (2018-2025)
Table Plasma-Derived Drugs Market Forecast by Regions (2018-2025)
Figure North America Plasma-Derived Drugs Market Forecast (2018-2025)
Figure United States Plasma-Derived Drugs Market Forecast (2018-2025)
Figure Canada Plasma-Derived Drugs Market Forecast (2018-2025)
Figure Mexico Plasma-Derived Drugs Market Forecast (2018-2025)
Figure Europe Plasma-Derived Drugs Market Forecast (2018-2025)
Figure Germany Plasma-Derived Drugs Market Forecast (2018-2025)
Figure France Plasma-Derived Drugs Market Forecast (2018-2025)
Figure UK Plasma-Derived Drugs Market Forecast (2018-2025)
Figure Russia Plasma-Derived Drugs Market Forecast (2018-2025)
Figure Italy Plasma-Derived Drugs Market Forecast (2018-2025)
Figure Rest of Europe Plasma-Derived Drugs Market Forecast (2018-2025)
Figure Asia-Pacific Plasma-Derived Drugs Market Forecast (2018-2025)
Figure China Plasma-Derived Drugs Market Forecast (2018-2025)
Figure Japan Plasma-Derived Drugs Market Forecast (2018-2025)
Figure Korea Plasma-Derived Drugs Market Forecast (2018-2025)
Figure India Plasma-Derived Drugs Market Forecast (2018-2025)
Figure Southeast Asia Plasma-Derived Drugs Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Plasma-Derived Drugs Market Forecast (2018-2025)
Figure South America Plasma-Derived Drugs Market Forecast (2018-2025)
Figure Brazil Plasma-Derived Drugs Market Forecast (2018-2025)
Figure Argentina Plasma-Derived Drugs Market Forecast (2018-2025)
Figure Columbia Plasma-Derived Drugs Market Forecast (2018-2025)
Figure Rest of South America Plasma-Derived Drugs Market Forecast (2018-2025)
Figure Middle East and Africa Plasma-Derived Drugs Market Forecast (2018-2025)
Figure Saudi Arabia Plasma-Derived Drugs Market Forecast (2018-2025)
Figure United Arab Emirates Plasma-Derived Drugs Market Forecast (2018-2025)
Figure Egypt Plasma-Derived Drugs Market Forecast (2018-2025)
Figure Nigeria Plasma-Derived Drugs Market Forecast (2018-2025)
Figure South Africa Plasma-Derived Drugs Market Forecast (2018-2025)
Figure Turkey Plasma-Derived Drugs Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Plasma-Derived Drugs Market Forecast (2018-2025)
Figure Global Plasma-Derived Drugs Forecast by Product Type (2018-2025)
Figure Global Plasma-Derived Drugs Market Share Forecast by Product Type (2018-2025)
Figure Global Plasma-Derived Drugs Forecast by Product Type (2018-2025)
Figure Global Plasma-Derived Drugs Forecast by End User (2018-2025)
Figure Global Plasma-Derived Drugs Market Share Forecast by End User (2018-2025)
Figure Global Plasma-Derived Drugs Forecast by End User (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|